0Studies tracked
0Claims cite
0Videos use
Average study score: 2/100
Bibliography
Studies by this author
1 study attributed to Xia Wang on the platform. Click a card to read the full analysis.
Study
Evolution of direct RAS inhibitors: from undruggable target to clinical breakthroughs
This narrative review examines the evolution of direct RAS inhibitors, focusing on how previously 'undruggable' RAS mutations—especially KRASG12C—are now being targeted with covalent inhibitors, molecular glues, protein degraders, and pan-RAS strategies.